Depression stands as a formidable adversary, affecting millions of lives worldwide. Despite strides in treatment, conventional approaches often fail to provide relief for individuals grappling with treatment-resistant depression. However, amidst this challenge, a ray of hope emerges in the form of ketamine IV therapy.

Ketamine's therapeutic potential extends beyond its established role in aiding Treatment Resistant Depression. Recent research has unveiled its efficacy in addressing chronic pain conditions, marking a significant breakthrough in pain management strategies.

Among the myriad of pain modalities, Ketamine exhibits promise in alleviating the suffering associated with Peripheral Neuropathies, a debilitating condition characterized by nerve damage that often leads to persistent, agonizing pain.

A diverse range of psychedelic substances has been explored in clinical research programs for their potential impact on a range of mental health conditions. These conditions include severe treatment-resistant depression, terminal-illness related depression, ALS, end-of-life anxiety, severe treatment-resistant anxiety, generalized anxiety, and PTSD. Among the substances being researched are LSD, MDMA, and psilocybin.

In recent years, a resurgence of interest in psychedelics has ignited discussions and research into their therapeutic potential, revolutionizing mental health treatment. From classic substances like LSD and Psilocybin to the dissociative anesthetic Ketamine, these compounds offer new avenues for addressing mental health disorders beyond traditional pharmaceutical approaches.

In light of Matthew Perry's tragic death, the conversation surrounding ketamine therapy has intensified, underscoring the need for a deeper understanding of its therapeutic applications and safety considerations.

Are you considering ketamine infusions for mental health treatment or maybe you have already reaped the positive effects from them, but concerned about the financial aspect? One of the most common questions we get asked is “does my insurance cover ketamine infusions?”

It can be frustrating to finally find something that works for your treatment resistant depression, anxiety or neuropathic pain that insurance may not cover. 

Embarking on the endeavor of launching a ketamine clinic is both thrilling and complex. As with any business venture, it requires a considerable investment of both time and financial resources to establish a solid foundation.

While some medical clinics continue to look for ways to thrive or survive since the COVID-19 pandemic, some clinics have chosen a new offering to tack on to their existing niche or specialty that is adding new patients and new revenue to their business model.

When embarking on a path that few have ventured before, it's natural to be inundated with questions. The use of ketamine as a treatment for neuropathic pain and behavioral health disorders, particularly Treatment Resistant Depression (TRD), is still in its early stages. Therefore, the journey of starting your own ketamine business or clinic is no different and is filled with challenges and learning curves.